Aniruddha Mondal

Title: Aniruddha Mondal: Innovator in Pharmaceutical Chemistry

Introduction

Aniruddha Mondal is a notable inventor based in Falta, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of heterocyclic compounds. With a total of 2 patents to his name, Mondal's work focuses on innovative solutions for treating diseases associated with protein kinases.

Latest Patents

Aniruddha Mondal's latest patents include the invention of heterocyclic compounds as protein kinase inhibitors. The present invention provides a heterocyclic compound of formula (I), along with a pharmaceutically acceptable salt, a prodrug, or a hydrate thereof. This invention outlines a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, along with methods of production and use. Specifically, the invention aims to provide a compound of formula (I) that is useful for treating or preventing diseases, conditions, or disorders associated with protein kinases, particularly those related to the Janus Kinase family.

Career Highlights

Aniruddha Mondal is currently associated with Daiichi Sankyo Company, Limited, where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential impact on therapeutic strategies in treating various diseases.

Collaborations

Some of his notable coworkers include Ashwani Kumar Verma and Kumaragurubaran Nagaswamy, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Aniruddha Mondal's contributions to the field of pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in developing new therapeutic solutions. His work continues to pave the way for advancements in medical treatments.